NCT03749096View on ClinicalTrials.gov

Randomized Placebo Controlled Trial of IVIg in Glycine Receptor Antibody Positive Stiff-person Syndrome

PHASE3WithdrawnINTERVENTIONAL
0
Timeline

Start Date

December 7, 2018

Primary Completion Date

April 26, 2019

Study Completion Date

April 26, 2019

Conditions
Stiff-Person Syndrome
Interventions
DRUG

Intravenous Immunoglobulins, Human

Immunoglobulins are fractionated blood products made from pooled human plasma.

DRUG

Placebos

Normal Saline

Trial Locations (1)

55905

Mayo Clinic in Rochester, Rochester

Sponsors

Lead Sponsor

Mayo Clinic
All Listed Sponsors
collaborator

Grifols Biologicals, LLC

INDUSTRY

lead

Mayo Clinic

OTHER

NCT03749096 - Randomized Placebo Controlled Trial of IVIg in Glycine Receptor Antibody Positive Stiff-person Syndrome | Biotech Hunter | Biotech Hunter